Who has invested in Reistone Biopharma?

Huagai Capital, Shanghai Shengdi Pharmaceutical are named among the investors backing Reistone Biopharma.

Reistone Biopharma Funding: $100M Raised, Series A (2022)

Reistone Biopharma funding overview

Reistone Biopharma is based in Shanghai, China. Reistone Biopharma has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in May 2022. The round record for Reistone Biopharma runs through 2022; nothing later has been disclosed. Investors on record include Huagai Capital, Shanghai Shengdi Pharmaceutical. 2 distinct backers are named across the disclosed rounds.

Reistone Biopharma at a glance

Total raised: $100M
Latest round: Series A
Latest round date: May 2022
Headquarters: Shanghai, China
Notable investors: Huagai Capital, Shanghai Shengdi Pharmaceutical

Frequently asked about Reistone Biopharma funding

How much has Reistone Biopharma raised?: Reistone Biopharma has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Reistone Biopharma?: Huagai Capital, Shanghai Shengdi Pharmaceutical are named among the investors backing Reistone Biopharma.
What was the latest Reistone Biopharma funding round?: The most recent disclosed round is a Series A, announced in May 2022.
Where is Reistone Biopharma based?: Reistone Biopharma is based in Shanghai, China.
When did Reistone Biopharma last raise?: The last disclosed Reistone Biopharma round closed in May 2022 at Series A.

Totals shown for Reistone Biopharma aggregate every disclosed round on file. To see how that compares, browse the companies in Shanghai and the investors behind them below.

Reistone Biopharma Funding: $100M Raised, Series A (2022)

Reistone Biopharma funding overview

Reistone Biopharma at a glance

Frequently asked about Reistone Biopharma funding

Companies related to Reistone Biopharma (26)

Browse related funding lists (6)